PMC:7228307 / 48998-49159
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 976 | 62-70 | Gene | denotes | FcγRIIIa | Gene:2214 |
| 977 | 42-48 | Chemical | denotes | glycan | MESH:D011134 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T838 | 29-31 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T839 | 62-64 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T840 | 82-83 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 976 | 62-70 | Gene | denotes | FcγRIIIa | Gene:2214 |
| 977 | 42-48 | Chemical | denotes | glycan | MESH:D011134 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T281 | 0-161 | Sentence | denotes | Thus, the engineering of the Fc domain or glycan for improved FcγRIIIa binding is a powerful tool to create more potent and clinically effective anticancer mAbs. |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T281 | 0-161 | Sentence | denotes | Thus, the engineering of the Fc domain or glycan for improved FcγRIIIa binding is a powerful tool to create more potent and clinically effective anticancer mAbs. |